IE782353L - Ethyl 2-aryl allophanates, medicaments - Google Patents
Ethyl 2-aryl allophanates, medicamentsInfo
- Publication number
- IE782353L IE782353L IE782353A IE235378A IE782353L IE 782353 L IE782353 L IE 782353L IE 782353 A IE782353 A IE 782353A IE 235378 A IE235378 A IE 235378A IE 782353 L IE782353 L IE 782353L
- Authority
- IE
- Ireland
- Prior art keywords
- ethyl
- medicaments
- aryl
- allophanates
- nervous system
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 title abstract 3
- 210000003169 central nervous system Anatomy 0.000 abstract 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- WZKSXHQDXQKIQJ-UHFFFAOYSA-N F[C](F)F Chemical compound F[C](F)F WZKSXHQDXQKIQJ-UHFFFAOYSA-N 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to medicaments acting notably on the central nervous system and based on ethyl 2-aryl allophanates. They are based on an ethyl 2-aryl allophanate of the general formula: <IMAGE> in which R1,R2 and R3 may represent hydrogen, chlorine or bromine, a methyl radical (-CH3) or trifluoromethyl radical (-CF3). The medicaments are useful for the treatment of disorders of the central nervous system in humans and animals.
[GB2010812A]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7735907A FR2409752A1 (en) | 1977-11-29 | 1977-11-29 | MEDICINAL PRODUCT ACTING IN PARTICULAR ON THE CENTRAL NERVOUS SYSTEM BASED ON ARYL-2 ETHYL ALLOPHANATES |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE782353L true IE782353L (en) | 1979-05-29 |
| IE47594B1 IE47594B1 (en) | 1984-05-02 |
Family
ID=9198212
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE2353/78A IE47594B1 (en) | 1977-11-29 | 1978-11-28 | Medicaments acting notably on the central nervous system based on ethyl 2-aryl allophanates |
Country Status (10)
| Country | Link |
|---|---|
| JP (1) | JPS606331B2 (en) |
| BE (1) | BE872163A (en) |
| CH (1) | CH635746A5 (en) |
| DE (1) | DE2851495C2 (en) |
| FR (1) | FR2409752A1 (en) |
| GB (1) | GB2010812B (en) |
| IE (1) | IE47594B1 (en) |
| IT (1) | IT1107673B (en) |
| LU (1) | LU80573A1 (en) |
| NL (1) | NL7811642A (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2572726B1 (en) * | 1984-11-08 | 1986-12-19 | Francaise Sucrerie | ISOPROPYL PHENYL-2 ALLOPHANATE, PROCESS FOR THE PRODUCTION THEREOF AND ITS APPLICATION IN THE PHARMACEUTICAL FIELD |
| WO2026057953A1 (en) | 2024-09-13 | 2026-03-19 | Lesaffre Et Compagnie | Synthesis of ethanol by hydrogenation of carbon dioxide |
-
1977
- 1977-11-29 FR FR7735907A patent/FR2409752A1/en active Granted
-
1978
- 1978-11-21 BE BE191846A patent/BE872163A/en not_active IP Right Cessation
- 1978-11-23 GB GB7845728A patent/GB2010812B/en not_active Expired
- 1978-11-24 LU LU80573A patent/LU80573A1/en unknown
- 1978-11-27 NL NL7811642A patent/NL7811642A/en not_active Application Discontinuation
- 1978-11-28 CH CH1218578A patent/CH635746A5/en not_active IP Right Cessation
- 1978-11-28 IT IT52098/78A patent/IT1107673B/en active
- 1978-11-28 IE IE2353/78A patent/IE47594B1/en unknown
- 1978-11-28 JP JP53147065A patent/JPS606331B2/en not_active Expired
- 1978-11-28 DE DE2851495A patent/DE2851495C2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| CH635746A5 (en) | 1983-04-29 |
| FR2409752A1 (en) | 1979-06-22 |
| IT1107673B (en) | 1985-11-25 |
| IE47594B1 (en) | 1984-05-02 |
| DE2851495A1 (en) | 1979-05-31 |
| JPS606331B2 (en) | 1985-02-18 |
| NL7811642A (en) | 1979-05-31 |
| BE872163A (en) | 1979-05-21 |
| JPS5492939A (en) | 1979-07-23 |
| FR2409752B1 (en) | 1982-11-12 |
| GB2010812A (en) | 1979-07-04 |
| DE2851495C2 (en) | 1982-06-24 |
| IT7852098A0 (en) | 1978-11-28 |
| GB2010812B (en) | 1982-05-19 |
| LU80573A1 (en) | 1979-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3868076D1 (en) | HETEROCYCLIC DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND FUNGICIDES CONTAINING THEM AS ACTIVE INGREDIENTS. | |
| MX9100308A (en) | QUINUCLIDINE DERIVATIVES | |
| NL300128I1 (en) | Substituted isoxysols for the treatment of inflammation. | |
| MY117896A (en) | Quinazoline derivatives | |
| AU5799294A (en) | Isoxazole-4-carboxamides and hydroxy-alkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use | |
| WO2002055017A3 (en) | Method of treating autoimmune diseases | |
| EP0786995A4 (en) | ||
| UA27911C2 (en) | MEANS FOR TREATMENT OR PREVENTION OF PHYSIOLOGICAL DISORDERS CAUSED BY EXCESS TAKHIKININ | |
| DE69615682D1 (en) | N- (1-ALKYL-5-PHENYL-2,3,4,5-TETRAHYDRO-1-H-BENZO [B] [1,5] -DIAZEPIN-3-YL) -ACETAMIDE | |
| DE69101914D1 (en) | BRANCHED FRUCTO OLIGOSACCHARIDES, METHOD FOR THE PRODUCTION THEREOF AND USE OF THESE AGENTS. | |
| NO20002702L (en) | thienopyrimidine | |
| ATE206708T1 (en) | BENZIMIDAZOLONE DERIVATIVES WITH CENTRAL DOPAMINERGIC ACTIVITY | |
| DE60029929D1 (en) | USE OF PYRIDAZINO i4,5- (b) δ-INDOLE-1-ACETAMIDE DERIVATIVES FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF DISEASES CAUSED BY PERIPHERAL BENZODIAZEPINE RECEPTOR DISORDERS | |
| PT69525A (en) | ANIMAL TREATMENT FACILITY, PARTICULARLY EWES | |
| DE58905246D1 (en) | HETEROCYCLIC SUBSTITUTED ALKOXYCUMARINES, METHOD FOR THE PRODUCTION THEREOF AND THERAPEUTIC AGENTS CONTAINING THEM. | |
| AU3828699A (en) | Utilization of 2-hydroxy-4-trifluoromethylbenzoic acid derivatives as inhibitorsof the activation of the nuclear transcription factors nf-Kappa | |
| FI962976L (en) | Compositions for the treatment of glaucoma containing a beta-blocker | |
| ES2194102T3 (en) | NEW N- (2,4-DIOXO-2,3,4,5-TETRAHIDRO-1H-1,5-BENZODIAZEPIN-3-IL) -3-AMIDAS. | |
| ATE87333T1 (en) | SMALL RHINOVIRUS RECEPTOR GROUP RECEPTOR. | |
| GB2010812A (en) | Medicaments acting notably on the central nervous system based on ethyl 2-aryl allophanates | |
| NO954892D0 (en) | Heterocyclic chemistry | |
| NO913117L (en) | PROCEDURE FOR THE TREATMENT OF NECESSARY DISEASES. | |
| NO984651L (en) | Use of benzone-offset derivatives for the manufacture of drugs for the treatment of central nervous system diseases | |
| DE69925160D1 (en) | ARYLPIPERIDINE AND ARYL 1,2,5,6-TETRAHYDROPYRIDINAMIDE DERIVATIVES WITH 5HT1A RECEPTOR ACTIVITY | |
| DE3069265D1 (en) | Total synthesis of (1rs, 4sr, 5rs)-4-(4,8-dimethyl-5-hydroxy-7-nonenyl)-4-methyl-3,8-dioxabicyclo (3.2.1) octane-1-acetic acid and intermediates |